NBIX
Neurocrine Biosciences, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #786
- Final score
- 31.53
- Years on list
- 7
↗ Climbed 43 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 43 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 127 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 226 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | NBIX | UTHR | JAZZ |
|---|---|---|---|
| Climate Change | 34.8 | 30.0 | 27.8 |
| Employee Relations | 39.7 | 46.8 | 36.8 |
| Environment | 25.8 | 15.9 | 17.5 |
| Stakeholders & Society | 21.1 | 47.1 | 51.3 |
| Human Rights | 14.8 | 4.7 | 9.7 |
| Governance | 43.9 | 43.1 | 33.0 |
| Performance Rating | 50.7 | 53.0 | 51.0 |